ObsEva Past Earnings Performance
Past criteria checks 4/6
ObsEva has been growing earnings at an average annual rate of 18.9%, while the Biotechs industry saw earnings growing at 12.7% annually. Revenues have been growing at an average rate of 79.3% per year. ObsEva's return on equity is 254.9%, and it has net margins of 40.3%.
Key information
18.9%
Earnings growth rate
32.3%
EPS growth rate
| Biotechs Industry Growth | 17.0% |
| Revenue growth rate | 79.3% |
| Return on equity | 254.9% |
| Net Margin | 40.3% |
| Next Earnings Update | 30 Apr 2024 |
Revenue & Expenses BreakdownBeta
How ObsEva makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 20 | 8 | 15 | -11 |
| 31 Mar 23 | 20 | -21 | 20 | -5 |
| 31 Dec 22 | 20 | -30 | 25 | 0 |
| 30 Sep 22 | 4 | -77 | 25 | 25 |
| 30 Jun 22 | 22 | -58 | 32 | -17 |
| 31 Mar 22 | 0 | -50 | 25 | 43 |
| 31 Dec 21 | 22 | -53 | 25 | 0 |
| 30 Sep 21 | 0 | -57 | 18 | 56 |
| 30 Jun 21 | 0 | -82 | 14 | 65 |
| 31 Mar 21 | 0 | -81 | 13 | 66 |
| 31 Dec 20 | 0 | -83 | 12 | 68 |
| 30 Sep 20 | 0 | -85 | 12 | 70 |
| 30 Jun 20 | 0 | -88 | 14 | 72 |
| 31 Mar 20 | 0 | -105 | 18 | 85 |
| 31 Dec 19 | 0 | -109 | 19 | 88 |
| 30 Sep 19 | 0 | -108 | 20 | 86 |
| 30 Jun 19 | 0 | -99 | 19 | 80 |
| 31 Mar 19 | 0 | -83 | 16 | 67 |
| 31 Dec 18 | 0 | -77 | 14 | 63 |
| 30 Sep 18 | 0 | -74 | 13 | 61 |
| 30 Jun 18 | 0 | -72 | 13 | 59 |
| 31 Mar 18 | 0 | -71 | 13 | 58 |
| 31 Dec 17 | 0 | -67 | 13 | 55 |
| 30 Sep 17 | 0 | -61 | 13 | 49 |
| 30 Jun 17 | 0 | -52 | 12 | 41 |
| 31 Mar 17 | 0 | -41 | 9 | 33 |
| 31 Dec 16 | 0 | -30 | 6 | 24 |
| 30 Sep 16 | 0 | -26 | 5 | 20 |
| 30 Jun 16 | 0 | -21 | 3 | 18 |
| 31 Mar 16 | 0 | -20 | 3 | 16 |
| 31 Dec 15 | 0 | -20 | 3 | 17 |
| 31 Dec 14 | 0 | -13 | 2 | 11 |
Quality Earnings: OBSE.F has high quality earnings.
Growing Profit Margin: OBSE.F became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OBSE.F has become profitable over the past 5 years, growing earnings by 18.9% per year.
Accelerating Growth: OBSE.F has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: OBSE.F has become profitable in the last year, making it difficult to compare its past year earnings growth to the Biotechs industry (-14%).
Return on Equity
High ROE: OBSE.F's Return on Equity (254.9%) is considered outstanding.